lzheimer’s disease (AD) is a form of dementia that affects the parts of the brain governing memory, thought, and language. It afflicts an estimated 6.7 million Americans—and is incredibly difficult to treat. The failure rate for clinical trials for Alzheimer’s treatments during the past 10 years is 98%. But such discouraging results have only intensified the
